CAPRELSA (vandetanib) Genzyme corp Patent: 7,173,038 Expiration: Aug 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expirations for the Week of August 8, 2021 appeared first on DrugPatentWatch - Make Better Decisions.